Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹868Cr
Rev Gr TTM
Revenue Growth TTM
28.77%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SKMEGGPROD
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 137.8 | 58.1 | 9.5 | -15.8 | -13.1 | -44.0 | -27.4 | -11.7 | -27.6 | 49.1 | 58.4 | 50.8 |
| 143 | 160 | 134 | 133 | 152 | 101 | 113 | 121 | 105 | 151 | 165 | 161 |
Operating Profit Operating ProfitCr |
| 23.3 | 23.9 | 23.5 | 13.3 | 6.5 | 14.2 | 11.6 | 10.4 | 10.5 | 14.1 | 18.5 | 21.0 |
Other Income Other IncomeCr | 3 | 2 | 1 | 1 | 9 | 3 | 3 | 2 | 5 | 4 | 3 | 5 |
Interest Expense Interest ExpenseCr | 4 | 2 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 4 |
Depreciation DepreciationCr | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 |
| 40 | 47 | 37 | 15 | 14 | 14 | 12 | 10 | 10 | 22 | 33 | 40 |
| 10 | 12 | 9 | 4 | 4 | 2 | 3 | 3 | 3 | 6 | 8 | 10 |
|
Growth YoY PAT Growth YoY% | 5,967.4 | 413.8 | 135.3 | -57.2 | -66.3 | -65.8 | -69.7 | -35.6 | -36.5 | 34.9 | 187.7 | 299.1 |
| 15.9 | 16.8 | 16.2 | 7.6 | 6.2 | 10.2 | 6.8 | 5.6 | 5.4 | 9.3 | 12.3 | 14.7 |
| 5.6 | 6.7 | 5.4 | 2.2 | 1.9 | 2.3 | 1.6 | 1.4 | 1.2 | 3.1 | 4.7 | 5.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 10.1 | 4.4 | -23.4 | 36.8 | 5.3 | -6.4 | -14.0 | 12.4 | 118.8 | 6.0 | -29.0 | 40.4 |
| 252 | 265 | 238 | 315 | 321 | 305 | 237 | 272 | 518 | 550 | 419 | 582 |
Operating Profit Operating ProfitCr |
| 13.0 | 12.4 | -2.6 | 0.9 | 4.0 | 2.5 | 11.9 | 10.2 | 21.8 | 21.5 | 15.8 | 16.8 |
Other Income Other IncomeCr | 16 | 13 | 23 | 20 | 8 | 20 | 13 | 8 | 1 | 13 | 14 | 17 |
Interest Expense Interest ExpenseCr | 5 | 3 | 5 | 5 | 4 | 6 | 4 | 4 | 9 | 10 | 11 | 13 |
Depreciation DepreciationCr | 13 | 12 | 12 | 13 | 11 | 14 | 21 | 24 | 34 | 40 | 35 | 16 |
| 35 | 35 | 0 | 5 | 6 | 8 | 21 | 10 | 103 | 114 | 46 | 105 |
| 10 | 11 | -1 | 3 | 1 | 3 | 4 | 3 | 27 | 29 | 12 | 27 |
|
| 251.2 | -2.5 | -93.6 | -18.1 | 269.5 | -2.3 | 247.2 | -54.8 | 927.7 | 12.4 | -59.5 | 123.9 |
| 8.8 | 8.2 | 0.7 | 0.4 | 1.4 | 1.5 | 6.1 | 2.4 | 11.5 | 12.2 | 7.0 | 11.1 |
| 9.7 | 4.7 | 0.3 | 0.2 | 0.9 | 0.9 | 3.1 | 1.4 | 14.4 | 16.2 | 6.6 | 14.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 |
| 42 | 64 | 65 | 66 | 70 | 73 | 88 | 94 | 168 | 251 | 277 | 312 |
Current Liabilities Current LiabilitiesCr | 65 | 68 | 74 | 80 | 73 | 93 | 80 | 97 | 114 | 129 | 120 | 179 |
Non Current Liabilities Non Current LiabilitiesCr | 17 | 10 | 7 | 8 | 12 | 11 | 14 | 16 | 30 | 63 | 71 | 64 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 80 | 98 | 106 | 113 | 112 | 135 | 135 | 159 | 237 | 316 | 300 | 392 |
Non Current Assets Non Current AssetsCr | 71 | 71 | 67 | 68 | 70 | 69 | 75 | 74 | 102 | 153 | 193 | 191 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 37 | 30 | -4 | 17 | 14 | -12 | 26 | 2 | 60 | 109 | 65 |
Investing Cash Flow Investing Cash FlowCr | -2 | -6 | -1 | -7 | -6 | -5 | -17 | -8 | -16 | -54 | -23 |
Financing Cash Flow Financing Cash FlowCr | -37 | -10 | -5 | -5 | -1 | -9 | -10 | -5 | -5 | 13 | -25 |
|
Free Cash Flow Free Cash FlowCr | 34 | 24 | -6 | 9 | 1 | -19 | 23 | -7 | 32 | 48 | 32 |
| 143.6 | 121.0 | -273.1 | 1,280.1 | 291.1 | -254.0 | 156.7 | 25.5 | 79.2 | 127.8 | 188.5 |
CFO To EBITDA CFO To EBITDA% | 97.1 | 80.3 | 71.8 | 579.4 | 104.8 | -155.3 | 80.3 | 6.1 | 41.7 | 72.4 | 83.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 392 | 236 | 214 | 224 | 133 | 81 | 123 | 162 | 342 | 568 | 426 |
Price To Earnings Price To Earnings | 15.7 | 9.8 | 130.8 | 177.6 | 27.4 | 17.4 | 7.6 | 21.8 | 4.5 | 6.6 | 12.3 |
Price To Sales Price To Sales | 1.4 | 0.8 | 0.9 | 0.7 | 0.4 | 0.3 | 0.5 | 0.5 | 0.5 | 0.8 | 0.9 |
Price To Book Price To Book | 5.7 | 2.6 | 2.3 | 2.4 | 1.4 | 0.8 | 1.1 | 1.4 | 1.8 | 2.0 | 1.4 |
| 11.3 | 6.7 | -39.5 | 85.5 | 11.4 | 16.4 | 5.3 | 7.2 | 2.6 | 3.8 | 5.4 |
Profitability Ratios Profitability Ratios |
| 31.1 | 31.7 | 17.5 | 16.4 | 21.3 | 21.7 | 30.5 | 29.9 | 39.7 | 37.7 | 34.9 |
| 13.0 | 12.4 | -2.6 | 0.9 | 4.0 | 2.5 | 11.9 | 10.2 | 21.8 | 21.5 | 15.8 |
| 8.8 | 8.2 | 0.7 | 0.4 | 1.4 | 1.5 | 6.1 | 2.4 | 11.5 | 12.2 | 7.0 |
| 36.4 | 30.3 | 3.9 | 7.1 | 7.4 | 8.2 | 14.4 | 7.1 | 39.6 | 29.4 | 12.8 |
| 37.2 | 27.6 | 1.7 | 1.4 | 5.0 | 4.7 | 14.3 | 6.2 | 39.0 | 30.8 | 11.4 |
| 16.9 | 14.7 | 0.9 | 0.7 | 2.6 | 2.3 | 7.8 | 3.2 | 22.4 | 18.2 | 7.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
SKM Egg Products Export (India) Limited is a leading vertically integrated poultry and egg processing company based in India. With a primary production hub in **Erode, Tamil Nadu**, the company has established itself as a high-standard producer for both domestic government contracts and sophisticated international markets. The company is currently undergoing a phase of capital restructuring and geographic expansion to enhance shareholder value and global market share.
---
### **Integrated Production & Biosecurity Infrastructure**
The company operates a closed-loop production system designed to mitigate biological risks and ensure consistent product quality. Its infrastructure is characterized by high-level biosecurity protocols and strategic geographic positioning.
* **Avian Influenza-Free Status:** The company’s poultry farms are officially recognized by the **Government of India** as an **Avian Influenza-Free Compartment**. This designation is critical for maintaining uninterrupted export operations.
* **Pathogen Surveillance:** Continuous monitoring is conducted for **Newcastle disease**, **Salmonella**, and **Avian Influenza**. Physical security measures, such as **chain-link systems** in bird waste areas, are utilized to prevent contact with wild birds and external vectors.
* **Geographic Risk Mitigation:** All egg production is concentrated in **Tamil Nadu**. By maintaining **no operations in Kerala**, the company effectively insulates its supply chain from regional avian influenza outbreaks frequently reported in neighboring states.
* **State Border Monitoring:** The company maintains enhanced surveillance at state border districts to prevent cross-border transmission of pathogens.
---
### **Revenue Streams & Strategic Market Positioning**
SKM Egg Products leverages a dual-market strategy, balancing stable domestic government contracts with high-growth international exports.
**Domestic Government Supply**
The company is a vital partner to the **Tamil Nadu state government**, recently securing a major contract for **Region-4** under the **PTMGR Nutritious Meal Programme** and the **Integrated Child Development Services (ICDS)**.
* **Tendered Quantity:** **28,62,49,572 eggs per annum**.
* **Contract Duration:** **One year** (commencing late 2024).
**Global Footprint and Expansion**
The company operates through a network of international subsidiaries and branches to facilitate global trade:
| Entity | Relationship | Location |
| :--- | :--- | :--- |
| **SKM Europe BV** | Subsidiary | Utrecht, **The Netherlands** |
| **SKM Universal Marketing Company India Pvt Ltd** | Associate | India |
| **Foreign Branch** | Branch Office | **Russia** |
* **Russian Operations:** In **FY25**, the Russian branch reported total assets of **Rs. 3,64,96,215** and total revenues of **Rs. 45,00,05,231**.
* **Japan Market Entry:** In **March 2026**, the Board approved the establishment of a **Branch Office in Japan**. This move is intended to capture specific business opportunities in the Japanese market, pending final approvals from the **Reserve Bank of India (RBI)** and Japanese regulatory authorities.
---
### **Capital Restructuring & Shareholder Returns**
To improve stock liquidity and encourage retail participation, the company executed a significant capital restructuring in early **2026**.
**Stock Split Details (January 2026)**
* **Split Ratio:** **1:2** (Sub-division of **1** equity share of **Rs. 10/-** into **2** shares of **Rs. 5/-** each).
* **Authorized Share Capital:** **Rs. 30,00,00,000**, divided into **6,00,00,000** equity shares.
* **New ISIN:** **INE411D01023**.
* **Strategic Intent:** The split was designed to enhance affordability and liquidity without reducing the total value of issued, subscribed, and paid-up capital.
**Dividend Track Record**
The company maintains a consistent policy of rewarding shareholders through annual dividends:
| Metric | FY 2024-25 | FY 2023-24 |
| :--- | :--- | :--- |
| **Dividend per Share** | **Rs. 1.50** | **Rs. 2.50** |
| **Dividend Percentage** | **15%** | **25%** |
| **Face Value (Pre-split)** | **Rs. 10** | **Rs. 10** |
---
### **Credit Profile & Financial Governance**
The company’s financial stability is supported by reaffirmed credit ratings and a robust governance framework involving state-level stakeholders.
**CARE Ratings Affirmation**
The company’s creditworthiness reflects a stable outlook and increased borrowing capacity to support its expanding operations:
| Facility Type | Amount (Rs. Crore) | Rating |
| :--- | :--- | :--- |
| **Long-term Bank Facilities** | **54.50** | **CARE A-; Stable** |
| **Long-term / Short-term Facilities** | **90.00** (Enhanced) | **CARE A-; Stable / CARE A2+** |
| **Short-term Bank Facilities** | **70.00** (Enhanced) | **CARE A2+** |
**Governance Highlights**
* **TIDCO Representation:** The board includes a **Nominee Director** from the **Tamil Nadu Industrial Development Corporation (TIDCO)**, ensuring alignment with state industrial interests.
* **Leadership Continuity:** Independent Directors **Shri. TN Thirukumar** and **Shri. GN Jayaram** have been re-appointed for second five-year terms (through **July 2029**).
* **Compliance:** Financials are prepared in accordance with **Indian Accounting Standards (Ind AS)** and **SEBI (LODR) Regulations**.
---
### **Risk Management & Compliance Framework**
SKM Egg Products manages a specific set of risks related to the biological nature of its products and its corporate structure.
* **Biological Risk:** While the poultry industry is susceptible to disease, the company’s **100% production concentration in Tamil Nadu** and its **Government-recognized disease-free status** serve as primary mitigants.
* **Related Party Transactions (RPT):** The company engages in material contracts with related parties that may exceed **10% of annual consolidated turnover**.
* **Mitigation:** All such transactions require an **Ordinary Resolution** by shareholders. To ensure transparency, related parties are legally required to **abstain from voting** on these specific resolutions.
* **Administrative Support:** Following a merger in **December 2023**, **Link Intime India Private Limited** serves as the Registrar & Share Transfer Agent, ensuring streamlined investor services.